Meet Our New Customer Support Representative

Meet Our New Customer Support Representative

At Kerafast, our list of providing institutions and portfolio of unique bioreagents continues to grow – and with that, so does our number of customers. We’ve now shipped reagents to customers in 53 different countries across six continents! As a result of this growth, we’ve expanded our customer service team and are excited to welcome 

Continue Reading…

Scientists Prevent Nerve Cell Death and Neurodegenerative Disease Progression

Scientists Prevent Nerve Cell Death and Neurodegenerative Disease Progression

In a new Nature Medicine study, a team of researchers from Case Western Reserve University School of Medicine have discovered how an RNA-binding protein may contribute to ALS disease progression. ALS (Amyotrophic Lateral Sclerosis, or Lou Gehrig’s disease) is a progressive and ultimately fatal neurological disease that attacks the motor nerve cells within the body. 

Continue Reading…

Reversing aging in adult stem cells

Reversing aging in adult stem cells

Researchers from the University at Buffalo have reversed aging in adult stem cells via a single transcription factor called NANOG. Their results, published in the journal Stem Cells, add to our understanding of the aging process and could aid in the development of treatments for various age-related illnesses, including atherosclerosis, osteoporosis and Alzheimer’s disease. The 

Continue Reading…

New information on Zika virus heightens concern

New information on Zika virus heightens concern

The public health concern over the Zika outbreak continues to escalate as new details on the transmission and localization of infected mosquitoes emerge. Recently in New York City, evidence of the first sexual transmission of the virus from a female to a male was reported by the United States Centers for Disease Control (CDC). Although 

Continue Reading…

Researchers Identify Gut Microbiome as New Therapeutic Target for Alzheimer’s Disease

Researchers Identify Gut Microbiome as New Therapeutic Target for Alzheimer’s Disease

Alzheimer’s disease (AD) is a progressive disease affecting the brain and is currently ranked the sixth leading cause of death in the United States. Symptoms of AD generally manifest in a person’s mid-60s and include loss of memory and cognitive function. As the disease progresses, extracellular deposits of amyloid-β (Aβ) peptides and intraneuronal neurofibrillary tangles 

Continue Reading…

Kerafast Expands List of International Providing Institutions

Kerafast Expands List of International Providing Institutions

Key partners add to growing list of academic institutions making reagents available Boston, MA., August 2, 2016.  Kerafast Inc., developers of an online platform to facilitate accessibility to unique bioresearch materials from laboratories across the globe, today announced an increase in the number of international institutional laboratories adding reagents and services to its catalog.  Kerafast 

Continue Reading…